New Zealand Molecular Diagnostics Market Size & Outlook

Name: New Zealand Molecular Diagnostics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The molecular diagnostics market in New Zealand is expected to reach a projected revenue of US$ 130.1 million by 2030. A compound annual growth rate of 3.4% is expected of New Zealand molecular diagnostics market from 2025 to 2030.

New Zealand molecular diagnostics product outlook (Revenue, USD million, 2018-2030)
- Instruments
- Reagents
- Others Product
New Zealand molecular diagnostics test location outlook (Revenue, USD million, 2018-2030)
- Point of care
- Self test or OTC
- Central laboratories
New Zealand molecular diagnostics technology outlook (Revenue, USD million, 2018-2030)
- PCR
  - Procedure
    - Nucleic Acid Extraction
    - Others Procedure
  - Type
    - Others
    - Multiplex
  - Product
    - Instruments PCR
    - Reagents PCR
    - Others PCR
- ISH
  - Instruments ISH
  - Reagents ISH
  - Others ISH
- INAAT
  - Instruments INAAT
  - Reagents INAAT
  - Others INAAT
- Chips and microarrays
  - Instruments Chips and microarrays
  - Reagents Chips and microarrays
  - Others Chips and microarrays
- Mass spectrometry
  - Instruments Mass spectrometry
  - Reagents Mass spectrometry
  - Others Mass spectrometry
- Sequencing
  - Instruments Sequencing
  - Reagents Sequencing
  - Others Sequencing
- TMA
  - Instruments TMA
  - Reagents TMA
  - Others TMA
- Others Technology
  - Instruments Others Technology
  - Reagents Others Technology
  - Others Others Technology
New Zealand molecular diagnostics application outlook (Revenue, USD million, 2018-2030)
- Oncology
  - Breast Cancer
  - Prostate Cancer
  - Colorectal Cancer
  - Cervical
  - Kidney
  - Liver
  - Blood
  - Lung
  - Other Oncology
- Pharmacogenomics
- Infectious disease
  - MRSA
  - Clostridium difficile
  - Vancomycin-resistant enterococci
  - Carbapenem-resistant bacteria testing
  - Respiratory syncytial virus (RSV)
  - Candida
  - Tuberculosis and drug-resistant TB
  - Meningitis
  - Gastro-intestinal panel testing
  - Chlamydia
  - Gonorrhea
  - HIV
  - Hepatitis C
  - Hepatitis B
  - Other Infectious Diseases
  - Flu
- Genetic testing
  - Newborn screening
  - Predictive and presymptomatic testing
  - Others Genetic testing
- Neurological disease
- Cardiovascular disease
- Microbiology
- Others Application

New Zealand Molecular Diagnostics Market Size & Outlook

Sign up - it's easy, and free!